Medicus Pharma Ltd.
MDCX
$0.30
-$0.04-10.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -352.79% | -297.34% | -76.54% | -122.54% | -109.90% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,164.12% | 9,343.19% | -47.82% | 41.16% | 28.08% |
| Change in Net Operating Assets | 1,631.91% | 116.19% | -35.06% | -23.07% | -93.05% |
| Cash from Operations | -122.27% | -85.36% | -109.64% | -155.34% | -146.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 129.41% | 129.41% | -13.00% | 934.50% | 934.50% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 275.74% | 299.06% | 21.14% | 121.21% | 47.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 151.65% | 156.86% | 7.70% | 193.25% | 126.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.71% | 1,592.33% | -84.73% | 568.76% | 68.43% |